Cerus Operating Margin 2010-2025 | CERS
Current and historical operating margin for Cerus (CERS) over the last 10 years. The current operating profit margin for Cerus as of March 31, 2025 is -10.23%.
| Cerus Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.21B | $-0.01B | -5.77% |
| 2024-12-31 | $0.20B | $-0.01B | -6.93% |
| 2024-09-30 | $0.20B | $-0.01B | -6.06% |
| 2024-06-30 | $0.19B | $-0.02B | -8.25% |
| 2024-03-31 | $0.19B | $-0.02B | -12.57% |
| 2023-12-31 | $0.19B | $-0.03B | -16.13% |
| 2023-09-30 | $0.18B | $-0.04B | -22.28% |
| 2023-06-30 | $0.18B | $-0.04B | -23.50% |
| 2023-03-31 | $0.18B | $-0.04B | -20.77% |
| 2022-12-31 | $0.19B | $-0.03B | -18.09% |
| 2022-09-30 | $0.19B | $-0.03B | -16.58% |
| 2022-06-30 | $0.18B | $-0.04B | -19.13% |
| 2022-03-31 | $0.17B | $-0.04B | -24.28% |
| 2021-12-31 | $0.16B | $-0.05B | -30.00% |
| 2021-09-30 | $0.14B | $-0.06B | -38.19% |
| 2021-06-30 | $0.13B | $-0.06B | -44.27% |
| 2021-03-31 | $0.12B | $-0.06B | -49.17% |
| 2020-12-31 | $0.12B | $-0.06B | -50.43% |
| 2020-09-30 | $0.11B | $-0.06B | -56.07% |
| 2020-06-30 | $0.10B | $-0.06B | -62.38% |
| 2020-03-31 | $0.10B | $-0.07B | -67.71% |
| 2019-12-31 | $0.09B | $-0.07B | -70.97% |
| 2019-09-30 | $0.09B | $-0.07B | -74.71% |
| 2019-06-30 | $0.08B | $-0.06B | -74.70% |
| 2019-03-31 | $0.08B | $-0.06B | -72.50% |
| 2018-12-31 | $0.08B | $-0.06B | -73.33% |
| 2018-09-30 | $0.07B | $-0.05B | -68.92% |
| 2018-06-30 | $0.07B | $-0.05B | -72.06% |
| 2018-03-31 | $0.06B | $-0.05B | -86.67% |
| 2017-12-31 | $0.05B | $-0.06B | -111.76% |
| 2017-09-30 | $0.04B | $-0.06B | -138.64% |
| 2017-06-30 | $0.04B | $-0.06B | -153.66% |
| 2017-03-31 | $0.04B | $-0.06B | -164.10% |
| 2016-12-31 | $0.04B | $-0.06B | -156.41% |
| 2016-09-30 | $0.04B | $-0.06B | -164.86% |
| 2016-06-30 | $0.04B | $-0.06B | -180.00% |
| 2016-03-31 | $0.04B | $-0.06B | -177.14% |
| 2015-12-31 | $0.04B | $-0.06B | -174.29% |
| 2015-09-30 | $0.04B | $-0.06B | -168.57% |
| 2015-06-30 | $0.04B | $-0.05B | -145.95% |
| 2015-03-31 | $0.04B | $-0.05B | -132.43% |
| 2014-12-31 | $0.04B | $-0.04B | -118.92% |
| 2014-09-30 | $0.04B | $-0.04B | -108.33% |
| 2014-06-30 | $0.04B | $-0.04B | -97.30% |
| 2014-03-31 | $0.04B | $-0.03B | -84.21% |
| 2013-12-31 | $0.04B | $-0.03B | -70.00% |
| 2013-09-30 | $0.04B | $-0.02B | -57.14% |
| 2013-06-30 | $0.04B | $-0.02B | -51.28% |
| 2013-03-31 | $0.04B | $-0.02B | -47.37% |
| 2012-12-31 | $0.04B | $-0.02B | -48.65% |
| 2012-09-30 | $0.04B | $-0.02B | -47.22% |
| 2012-06-30 | $0.04B | $-0.02B | -43.24% |
| 2012-03-31 | $0.04B | $-0.02B | -48.57% |
| 2011-12-31 | $0.03B | $-0.02B | -48.48% |
| 2011-09-30 | $0.03B | $-0.02B | -62.07% |
| 2011-06-30 | $0.03B | $-0.02B | -76.00% |
| 2011-03-31 | $0.02B | $-0.02B | -70.83% |
| 2010-12-31 | $0.02B | $-0.02B | -73.91% |
| 2010-09-30 | $0.02B | $-0.02B | -77.27% |
| 2010-06-30 | $0.02B | $-0.02B | -86.36% |
| 2010-03-31 | $0.02B | $-0.02B | -100.00% |
| 2009-12-31 | $0.02B | $-0.02B | -135.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.296B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.442B | 27.95 |
| Boston Scientific (BSX) | United States | $153.655B | 38.47 |
| Stryker (SYK) | United States | $150.679B | 31.51 |
| EssilorLuxottica (ESLOY) | France | $135.238B | 0.00 |
| Medtronic (MDT) | Ireland | $114.659B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.418B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.416B | 25.92 |
| ResMed (RMD) | United States | $37.840B | 28.42 |
| Agilent Technologies (A) | United States | $35.272B | 22.99 |
| GE HealthCare Technologies (GEHC) | United States | $35.028B | 16.63 |
| Terumo (TRUMY) | Japan | $24.711B | 32.10 |
| Koninklijke Philips (PHG) | Netherlands | $23.746B | 16.66 |
| Insulet (PODD) | United States | $20.930B | 82.15 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.825B | 12.09 |
| Baxter (BAX) | United States | $15.241B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.608B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.072B | 24.61 |
| Lantheus Holdings (LNTH) | United States | $5.800B | 14.63 |
| Prestige Consumer Healthcare (PBH) | United States | $3.832B | 17.12 |
| Haemonetics (HAE) | United States | $3.755B | 17.10 |
| Perrigo (PRGO) | Ireland | $3.749B | 9.50 |
| Envista Holdings (NVST) | United States | $3.512B | 29.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 24.91 |
| QuidelOrtho (QDEL) | United States | $2.134B | 14.67 |
| LeMaitre Vascular (LMAT) | United States | $1.937B | 43.31 |
| AtriCure (ATRC) | United States | $1.587B | 0.00 |
| Acuren (TIC) | United States | $1.427B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.357B | 30.52 |
| AdaptHealth (AHCO) | United States | $1.275B | 12.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Neogen (NEOG) | United States | $1.211B | 15.50 |
| BioLife Solutions (BLFS) | United States | $1.087B | 0.00 |
| InMode (INMD) | Israel | $0.960B | 9.67 |
| Curaleaf Holdings (CURLF) | Canada | $0.818B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.780B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.736B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.641B | 0.00 |
| Owens & Minor (OMI) | United States | $0.640B | 5.31 |
| Evolus (EOLS) | United States | $0.627B | 0.00 |
| CeriBell (CBLL) | United States | $0.606B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.511B | 0.00 |
| Surmodics (SRDX) | United States | $0.444B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| Cresco Labs (CRLBF) | United States | $0.342B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.307B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 78.17 |
| ZimVie (ZIMV) | United States | $0.262B | 11.90 |
| Brainsway (BWAY) | Israel | $0.239B | 63.17 |
| Biote (BTMD) | United States | $0.230B | 6.48 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Omeros (OMER) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.14 |
| Vireo Growth (VREOF) | United States | $0.164B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.91 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.57 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |